Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
Pediatric Hematology and Oncology|June 11, 2016
Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastomaJohanna Theruvath, Alexandra Russo, Bettina Kron, et al.International Journal of Molecular Sciences|September 13, 2025
Ganglioside Profiling Uncovers Distinct Patterns in High-Risk NeuroblastomaClaudia Paret, Arthur Wingerter, Larissa Seidmann, et al.Frontiers in Pediatrics|June 26, 2020
Benefits of Exercise Training for Children and Adolescents Undergoing Cancer Treatment: Results From the Randomized Controlled MUCKI TrialSandra Stössel, Marie A Neu, Arthur Wingerter, et al.Cancer Medicine|March 7, 2019
Prevalence of mental distress among adult survivors of childhood cancer in Germany-Compared to the general populationJuliane Burghardt, Eva Klein, Elmar Brähler, et al.Haematologica|August 5, 2021
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study GroupGabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, et al.Virchows Archiv : an International Journal of Pathology|February 23, 2018
Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?Tobias M Dantonello, Christian Vokuhl, Monika Scheer, et al.Translational Vision Science & Technology|October 27, 2025
Altered Neuroretinal Tissue in Childhood Cancer Survivors: Data From the German CVSS StudyAlexander K Schuster, Anna Maria Welzel, Tamara Jäger, et al.Oncotarget|November 9, 2016
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapyClaudia Paret, Johanna Theruvath, Alexandra Russo, et al.International Journal of Molecular Sciences|June 26, 2019
IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor PatientsNadine Vewinger, Sabrina Huprich, Larissa Seidmann, et al.Oncoimmunology|March 6, 2023
Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALLNicole Ziegler, Mariela Cortés-López, Francesca Alt, et al.Pageof 9